Speeding the Root Cause Analysis (RCA) in regulated manufacturing has never been that easy

When a deviation or nonconformance happens in a regulated industrial plant, the clock starts ticking: product on hold, scrap risk, OEE impact, and a future audit that will demand full traceability.

In that moment, Root Cause Analysis (RCA) isn’t a quality exercise, it’s the mechanism that separates a quick correction from a sustainable fix.

1) RCA “without a platform”: the traditional approach

In many organizations, RCA relies on solid practices… but the tools are scattered.

What typically happens

• Reactive detection: the deviation is confirmed hours later (lab results, end-of-shift trend review, isolated alarms).
• Manual evidence hunting and reconstruction: exporting SCADA trends to Excel, querying historians, reviewing maintenance work orders, setpoint changes, shifts, lots, etc.
• Iterative hypotheses: the team tests correlations “by hand” until something becomes conclusive.
• Manual CAPA documentation: a large share of the effort goes to writing, consolidating, and justifying the investigation for audit.

Typical tools (and their limits)

• Excel / shared spreadsheets: useful, but prone to version errors and weak data lineage.
• Analysis methods (when used well):
• QMS + email + folders: the case fragments; traceability exists, but it requires time and discipline.

The problem isn’t the method—it’s the operational cost of “forensics”

If the team spends most of its time finding and organizing evidence, there’s less time left for what truly reduces recurrence: validating hypotheses, deciding actions, and verifying effectiveness.

2) RCA “with Intemic”: unify evidence + guide the analysis + automate documentation

A platform-based approach starts from a simple premise: if RCA depends on scattered data, the bottleneck is integration.

What changes with a platform

• One case, one evidence container
• Timeline and traceability by default
• Assisted analysis
• Audit-ready CAPA

Why this fits especially well in regulated environments

Guidelines such as ICH Q10 describe CAPA as a core element of the Pharmaceutical Quality System and emphasize a structured investigation approach aimed at determining root cause.

In other words: it’s not enough to “close” the deviation—you must close it in a way that’s risk-proportionate, documented, and verifiable.

Closing

RCA doesn’t fail due to lack of intent or expertise. It fails because, too often, the team must act as “data archaeologists” before any real analysis can begin.

A platform-based approach turns RCA into a faster, more traceable, and more repeatable process—and allows the team’s effort to go where it matters: evidence-based conclusions + effective CAPAs + accumulated learning.